Effect of <i>N</i>-Terminal Peptide Modifications on In Vitro and In Vivo Properties of ¹⁷⁷Lu-Labeled Peptide Analogs Targeting CCK2R

The therapeutic potential of minigastrin (MG) analogs for the treatment of cholecystokinin-2 receptor (CCK2R)-expressing cancers is limited by poor in vivo stability or unfavorable accumulation in non-target tissues. Increased stability against metabolic degradation was achieved by modifying the C-t...

全面介紹

書目詳細資料

發表在:	Pharmaceutics
Main Authors:	Anton Amadeus Hörmann, Maximilian Klingler, Christine Rangger, Christian Mair, Lieke Joosten, Gerben M. Franssen, Peter Laverman, Elisabeth von Guggenberg
格式:	Article
語言:	英语
出版:	MDPI AG 2023-02-01
主題:	cholecystokinin-2 receptor gastrin peptide receptor radionuclide therapy lutetium-177 theranostics
在線閱讀:	https://www.mdpi.com/1999-4923/15/3/796